Strategies & Technologies Driving Drug Discovery to Market
Human Drug Metabolism Enzymes
March 6, 2009 11:27 am | Product Releases | CommentsPREMAS Biotech launched its suite of recombinant Human Cytochrome P450 Isozymes expressed in Saccharomyces cerevisiae.
Drug Pipeline Progress - March 1-7
March 6, 2009 10:21 am | News | CommentsThe latest clinical trials, updates, orphan drug designations, and FDA approvals from pharma and biotech companies.
PETG Containers
March 6, 2009 9:27 am | Product Releases | CommentsThermo Fisher Scientific Inc. introduced the Thermo Scientific Nalgene Certified Clean PETG Containers.
Roche Increases Offer Price for Genentech Shares
March 6, 2009 7:23 am | News | CommentsRoche announced that it has increased its offer price for all outstanding publicly-held shares of Genentech.
Drug Combination May Be Effective Against Melanoma
March 6, 2009 6:04 am | News | CommentsBy targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy.
Inappropriate Drug Prescriptions Potentially Wasting Millions
March 6, 2009 5:48 am | News | CommentsA recent study in Oregon suggests that drugs designed for treating the most severe mental illnesses are often prescribed at inappropriately low doses and at considerable expense, for use in conditions where their benefit has not been established.
Gene Searching Method Finds New Targets for Crohn's Drugs
March 6, 2009 5:38 am | News | CommentsUsing a novel approach researchers has discovered new genes involved in Crohn's disease.
Drug Therapy for Brain Tumours
March 6, 2009 5:15 am | News | CommentsThe combination of two drugs produces a critical improvement in the treatment of certain brain tumours.
Winning the Race?
March 6, 2009 5:03 am | by James Netterwald, PhD, MT (ASCP), Senior Editor | Articles | CommentsThe technology used to sequence the first genome 13 years is too slow and too costly by today’s standards. Fortunately, next-generation and third-generation sequencing technologies are competing for first place in the genomics marathon.
Clinical Trial Finds Microbicide Promising as HIV Prevention Method
March 6, 2009 4:12 am | News | CommentsA clinical trial involving more than 3,000 women in the US and southern Africa demonstrates the promise of a vaginal microbicide gel for preventing HIV infection in women.
'Personalized' Genome Sequencing Finds Disease-Causing Genes
March 6, 2009 4:00 am | News | CommentsScientists at the Sol Goldman Pancreatic Cancer Research Center at the Johns Hopkins Kimmel Cancer Center have used ‘personalized genome’ sequencing on an individual with a hereditary form of pancreatic cancer to locate a mutation in a gene called PALB2 that is responsible for initiating the disease.
Transparent Zebrafish: A Model for Atherosclerosis
March 6, 2009 3:49 am | News | CommentsFish are helping researchers better understand how heart disease develops in studies that could lead to new drugs to slow disease and prevent heart attacks.
Symphogen and Origen Collaborate
March 6, 2009 3:32 am | News | CommentsSymphogen A/S and Origen Therapeutics announced a strategic collaboration to develop a transgenic chicken capable of producing human antibodies against a wide variety of disease targets.
Millennium Initiates Two Phase 2 Trials of Novel Aurora A Kinase Inhibitor
March 6, 2009 3:23 am | News | CommentsMillennium Pharmaceuticals, Inc., announced that it has initiated two Phase 2 clinical trials of MLN8237.
HIV Mutations Vital to Tracking AIDS Epidemic
March 6, 2009 3:14 am | News | CommentsIn a collaborative study, researchers at the Stanford University School of Medicine have compiled a list of 93 common mutations of the AIDS virus associated with drug resistance that will be used to track future resistance trends throughout the world.
